CWA
DTIL icon

Capital Wealth Alliance’s Precision BioSciences DTIL Stock Holding History

Capital Wealth Alliance’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-17
Closed -$4K – 142
2019
Q4 		$4K Buy
+17
New +$5.34K ﹤0.01% 257

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
ACWM
Adams Chetwood Wealth Management Durham, North Carolina $176M AUM 8.48% 1-Year Est. Return

Capital Wealth Alliance's DTIL Position: Q1 2020 in Review

Capital Wealth Alliance sold out of Precision BioSciences (DTIL) in Q1 2020, closing a stake of 17 shares — an estimated $4K sold.

Capital Wealth Alliance first reported a position in DTIL in Q4 2019 and held it in 1 quarter. The position peaked at $4K in Q4 2019. 109 funds tracked by Wall St. Rank hold DTIL as of Q1 2020.

  • Capital Wealth Alliance reported no remaining Precision BioSciences position as of Q1 2020 after selling out during the quarter.
  • Capital Wealth Alliance sold 17 Precision BioSciences shares in Q1 2020, an estimated $4K.
  • Capital Wealth Alliance first reported a position in Precision BioSciences in Q4 2019 and held it in 1 quarter.
  • Capital Wealth Alliance's Precision BioSciences position peaked at $4K in Q4 2019.
  • 109 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2020.

Based on Capital Wealth Alliance's 13F filing for Q1 2020, filed 28 Apr 2020.